BioCryst Pharmaceuticals Depreciation & Amortization 2011-2026 | BCRX

Annual Depreciation & Amortization BioCryst Pharmaceuticals

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.25 M	1.66 M	1.44 M	777 K	748 K	724 K	770 K	704 K	483 K	180 K	177 K	304 K	628 K	886 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.66 M	177 K	766 K

Quarterly Depreciation & Amortization BioCryst Pharmaceuticals

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	331 K	-	-	-	306 K	-	-	-	405 K	-	1.04 M	-	317 K	-	606 K	-	178 K	-	568 K	401 K	218 K	-	539 K	357 K	176 K	-	572 K	377 K	186 K	-	522 K	344 K	172 K	-	311 K	136 K	47 K	-	137 K	94 K	45 K	-	137 K	97 K	53 K	-	247 K	183 K	97 K	-	461 K	325 K	168 K	-	630 K	445 K	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.04 M	45 K	312 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
AbCellera Biologics ABCL	18.4 M	$ 3.52	-1.26 %	$ 1.05 B	Canada
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	63 K	-	10.36 %	$ 9.8 M	USA
Aptorum Group Limited APM	1.13 M	$ 0.79	0.04 %	$ 4.31 M	China
Arcturus Therapeutics Holdings ARCT	3.02 M	$ 6.39	-3.62 %	$ 175 M	Israel
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Atea Pharmaceuticals AVIR	416 K	$ 6.07	0.33 %	$ 495 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Athersys ATHX	1.43 M	-	3.77 %	$ 22.4 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
BioCardia BCDA	84 K	$ 1.29	1.57 %	$ 27.3 M	USA
Anika Therapeutics ANIK	6.43 M	$ 14.45	0.63 %	$ 212 M	USA
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Aptose Biosciences APTO	32 K	-	-45.71 %	$ 1.2 M	Canada
AVEO Pharmaceuticals AVEO	67 K	-	-	$ 521 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	5.38 M	$ 2.59	-2.08 %	$ 16.3 M	USA
Autolus Therapeutics plc AUTL	7.55 M	$ 1.5	-0.99 %	$ 383 M	Britain
Athira Pharma ATHA	970 K	-	-	$ 269 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Actinium Pharmaceuticals ATNM	197 K	$ 1.15	3.6 %	$ 34.6 M	USA